Search results for "Cardiovascular events"
Warning about using sodium oxybate
This regulatory update covers warnings against mixing sodium oxybate with alcohol and against using dabigatran in patients with mechanical heart valves.
https://immattersacp.org/archives/2013/03/fda.htm
1 Mar 2013
GERD guidelines establish diagnosis, management options
The American Gastroenterological Society issued guidelines for the diagnosis and management of gastroesophageal reflux disease (GERD).
https://immattersacp.org/weekly/archives/2013/03/12/1.htm
12 Mar 2013
Chlorthalidone associated with electrolyte abnormalities in older hypertensive patients
Chlorthalidone does not lead to fewer cardiovascular events and deaths than hydrochlorothiazide but may be more likely to cause electrolyte imbalances, especially hypokalemia, according to a new study.
https://immattersacp.org/weekly/archives/2013/03/19/2.htm
19 Mar 2013
Warning on irregular heart rhythms with azithromycin
Azithromycin (Zithromax or Zmax) can cause abnormal changes in the electrical activity of the heart that may lead to a potentially fatal irregular heart rhythm, the FDA warned last week.
https://immattersacp.org/weekly/archives/2013/03/19/8.htm
19 Mar 2013
Letters to the Editor
Readers react to ACP Internist's coverage, offering more resources for alcohol screening and ways to rethink first-line treatment for hypertension.
https://immattersacp.org/archives/2013/04/letters.htm
1 Apr 2013
Azithromycin gets warning, incretin mimetics investigated
This regulatory update covers a new warning on azithromycin about abnormal changes in the electrical activity of the heart, and a possible increased risk of pancreatitis and precancerous findings from incretin mimetic drugs.
https://immattersacp.org/archives/2013/05/fda.htm
1 May 2013
Long-acting beta-agonists and anticholinergics pose similar cardiovascular risks
Patients with chronic obstructive pulmonary disease (COPD) faced increased risk of a cardiovascular event after starting treatment with a long-acting bronchodilator, whether it was a beta-agonist or an anticholinergic, a new study found.
https://immattersacp.org/weekly/archives/2013/06/04/4.htm
4 Jun 2013
Telmisartan and valsartan associated with fewer hospital admissions than other ARBs, study finds
In patients with diabetes, telmisartan and valsartan were associated with lower rates of hospitalization for cardiovascular events than other angiotensin-receptor blockers (ARBs), according to a recent retrospective study.
https://immattersacp.org/weekly/archives/2013/07/16/4.htm
16 Jul 2013
Diabetes debates defy easy resolution
An ever-changing knowledge base without clear consensus makes diabetes management especially challenging.
https://immattersacp.org/archives/2013/09/diabetes.htm
1 Sep 2013
Testosterone therapy may be associated with increased risk of mortality and cardiovascular events
Testosterone therapy was associated with increased risk of mortality, myocardial infarction (MI) or ischemic stroke among men in the Veterans Administration (VA) health care system, a study found.
https://immattersacp.org/weekly/archives/2013/11/12/4.htm
12 Nov 2013